Genetic basis of endocrine disease: pituitary tumor pathogenesis.

Pituitary tumors are mostly benign monoclonal adenomas arising from adenohypophyseal cells in the anterior pituitary. These tumors usually autonomously express and secrete pituitary hormones, leading to endocrinological syndromes, such as hyperprolactinemia (most common), acromegaly, Cushing’s disease, and, rarely, hyperthyroidism. Alternatively, they may be functionally silent and initially diagnosed as an expanding sellar mass resulting in hypopituitarism, usually with central hypogonadism, visual field defects, or headaches. Although our understanding of subcellular mechanisms for the pathogenesis and progression of these common tumors is incomplete, during recent years important new information on the role of intrinsic pituitary genetic alterations, disordered transcription factors and growth factors, and signaling proteins involved in pituitary tumorigenesis has been reported in both sporadic and hereditary adenomas (Table 1).

[1]  S. Melmed Pathogenesis of pituitary tumors. , 1999, Endocrinology and metabolism clinics of North America.

[2]  S. Melmed,et al.  Isolation and characterization of a pituitary tumor-transforming gene (PTTG). , 1997, Molecular endocrinology.

[3]  S. Melmed,et al.  Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. , 1997, The Journal of clinical investigation.

[4]  J. Dötsch,et al.  Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[5]  D. Nass,et al.  Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. , 1996, The Journal of clinical endocrinology and metabolism.

[6]  K. Post,et al.  Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors , 1996, International journal of cancer.

[7]  K. Post,et al.  Frequent loss of the P16INK4a gene product in human pituitary tumors. , 1996, Cancer research.

[8]  Nobuyuki Shishido,et al.  Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.

[9]  James M. Roberts,et al.  A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.

[10]  K. Manova-Todorova,et al.  Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.

[11]  S. Melmed,et al.  Structure of the thyrotrophin‐releasing hormone receptor in human pituitary adenomas , 1996, Clinical endocrinology.

[12]  J. Battey,et al.  Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes. , 1996, The Journal of clinical endocrinology and metabolism.

[13]  S. Melmed,et al.  Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription. , 1996, The Journal of clinical investigation.

[14]  S. Asa,et al.  Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. , 1995, Endocrinology.

[15]  T. Ohnishi,et al.  Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.

[16]  P. Chanson,et al.  The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. , 1995, Molecular endocrinology.

[17]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[18]  S. Melmed,et al.  Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness. , 1995, The Journal of clinical endocrinology and metabolism.

[19]  B. Scheithauer,et al.  Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. , 1995, Cancer research.

[20]  S. Asa,et al.  Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.

[21]  D. Harrison,et al.  G‐protein mutations in human pituitary adrenocorticotrophic hormone‐secreting adenomas , 1995, European journal of clinical investigation.

[22]  S. Asa,et al.  Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  S. Melmed,et al.  The IGF‐I receptor sub‐membrane domain is intact in GH‐secreting pituitary tumours , 1995, Clinical endocrinology.

[24]  P. Harris,et al.  Gsα and Gi2α mutations in clinically non‐functioning pituitary tumours , 1994 .

[25]  M. Brandi,et al.  Circulating fibroblast growth factor-like autoantibodies in two patients with multiple endocrine neoplasia type 1 and prolactinoma. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  S. Lightman,et al.  p53 gene mutations in pituitary adenomas: rare events , 1994, Clinical endocrinology.

[27]  M. Meurisse,et al.  Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome. , 1994, The Journal of clinical endocrinology and metabolism.

[28]  S. Melmed,et al.  Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. , 1994, The Journal of clinical endocrinology and metabolism.

[29]  I. Mason The ins and outs of fibroblast growth factors , 1994, Cell.

[30]  K. Post,et al.  Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors , 1994, Cancer.

[31]  B. Scheithauer,et al.  H-ras mutations in human pituitary carcinoma metastases. , 1994, The Journal of clinical endocrinology and metabolism.

[32]  A. Bradley,et al.  Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. , 1994, Oncogene.

[33]  D. Gilliland,et al.  Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. , 1994, The Journal of clinical endocrinology and metabolism.

[34]  C. Larsson,et al.  Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.

[35]  S. Melmed,et al.  Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.

[36]  R. Thakker,et al.  Molecular genetic studies of sporadic pituitary tumors. , 1994, The Journal of clinical endocrinology and metabolism.

[37]  Y. Nakamura,et al.  Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. , 1993, American journal of surgery.

[38]  R. Thakker,et al.  Multiple endocrine neoplasia type 1 (MEN1). , 1994, European journal of cancer.

[39]  B. Scheithauer,et al.  ras mutations in human prolactinomas and pituitary carcinomas. , 1994, The Journal of clinical endocrinology and metabolism.

[40]  G. Faglia,et al.  Cellular alterations in pituitary tumors. , 1994, European journal of endocrinology.

[41]  T. Sano,et al.  Analysis of the Gs α gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues , 1993 .

[42]  V. Cryns,et al.  The retinoblastoma gene in human pituitary tumors. , 1993, The Journal of clinical endocrinology and metabolism.

[43]  E. Friedman,et al.  Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. , 1993, The Journal of clinical endocrinology and metabolism.

[44]  S. Atkin,et al.  Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation. , 1993, The Journal of clinical endocrinology and metabolism.

[45]  Aldons J. Lusis,et al.  Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.

[46]  S. Melmed,et al.  Molecular screening of pituitary adenomas for gene mutations and rearrangements. , 1993, The Journal of clinical endocrinology and metabolism.

[47]  R. Thakker,et al.  Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. , 1993, The Journal of clinical investigation.

[48]  M. Brandi,et al.  Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. , 1993, The Journal of clinical endocrinology and metabolism.

[49]  K. Matsumoto,et al.  Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. , 1992, The Journal of clinical endocrinology and metabolism.

[50]  S. Asa,et al.  Transforming growth factor-α in normal and neoplastic human endocrine tissues , 1992 .

[51]  G. Faglia,et al.  G protein oncogenes in pituitary tumors , 1992, Trends in Endocrinology & Metabolism.

[52]  W. Young,et al.  Octreotide treatment of acromegaly. A randomized, multicenter study. , 1992, Annals of internal medicine.

[53]  E. Hedley‐Whyte,et al.  Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. , 1992, The Journal of clinical endocrinology and metabolism.

[54]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[55]  X. Bertagna,et al.  Monoclonality of corticotroph macroadenomas in Cushing's disease. , 1992, The Journal of clinical endocrinology and metabolism.

[56]  C. Francomano,et al.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[57]  E. Hedley‐Whyte,et al.  Ras mutations in human pituitary tumors. , 1992, The Journal of clinical endocrinology and metabolism.

[58]  M. Merino,et al.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. , 1991, The New England journal of medicine.

[59]  E. Oldfield,et al.  Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. , 1991, The Journal of clinical endocrinology and metabolism.

[60]  J. Fagin,et al.  Transforming DNA sequences present in human prolactin-secreting pituitary tumors. , 1991, Molecular endocrinology.

[61]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[62]  P. Sawchenko,et al.  Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant , 1991, Nature.

[63]  J. Norton,et al.  Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. , 1991, Cancer research.

[64]  K. Kovacs,et al.  Clonal origin of pituitary adenomas. , 1990, The Journal of clinical endocrinology and metabolism.

[65]  M. Arosio,et al.  Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. , 1990, The Journal of clinical endocrinology and metabolism.

[66]  H. Bourne,et al.  Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. , 1990, The Journal of clinical endocrinology and metabolism.

[67]  S. Rubin,et al.  Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. , 1990, Molecular endocrinology.

[68]  E. Kawasaki,et al.  Two G protein oncogenes in human endocrine tumors. , 1990, Science.

[69]  E. Clementi,et al.  A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours. , 1990, Oncogene.

[70]  A. Arnold,et al.  Clinically nonfunctioning pituitary tumors are monoclonal in origin. , 1990, The Journal of clinical investigation.

[71]  C. Larsson,et al.  Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Brandi,et al.  Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1. , 1990, The Journal of clinical endocrinology and metabolism.

[73]  L. Liotta,et al.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. , 1989, Cancer research.

[74]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[75]  H. Bourne,et al.  GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours , 1989, Nature.

[76]  P. Bouloux,et al.  Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. , 1989, The New England journal of medicine.

[77]  Y. Nakamura,et al.  Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. , 1989, The New England journal of medicine.

[78]  A. Paterson,et al.  Transforming Growth Factor-α Expression in the Anterior Pituitary Gland: Regulation by Epidermal Growth Factor and Phorbol Ester in Dispersed Cells , 1989 .

[79]  T. Sano,et al.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. , 1988, Endocrine reviews.

[80]  W. Lee,et al.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.

[81]  J. Yokota,et al.  Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[82]  C. Larsson,et al.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.

[83]  G. Giannattasio,et al.  Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas , 1987, Nature.

[84]  S. Asa,et al.  Alpha-transforming growth factor in the bovine anterior pituitary gland: secretion by dispersed cells and immunohistochemical localization. , 1987, Endocrinology.

[85]  H. Willard,et al.  Clonal analysis using recombinant DNA probes from the X-chromosome. , 1987, Cancer research.

[86]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[87]  D. Goeddel,et al.  Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .

[88]  M. Kobrin,et al.  Alpha-transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. I. Purification from conditioned medium. , 1986, The Journal of biological chemistry.

[89]  M. Kobrin,et al.  Alpha-transforming growth factor secreted by untransformed bovine anterior pituitary cells in culture. II. Identification using a sequence-specific monoclonal antibody. , 1986, The Journal of biological chemistry.

[90]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[91]  L. Swanson,et al.  Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[92]  D. Gospodarowicz,et al.  Fibroblast growth factor , 1986, Molecular and Cellular Endocrinology.

[93]  T. Sugimura,et al.  Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[94]  N. Ling,et al.  A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Hurley,et al.  Sequence of the alpha subunit of photoreceptor G protein: homologies between transducin, ras, and elongation factors. , 1985, Science.

[96]  S. Asa,et al.  Cushing's disease associated with an intrasellar gangliocytoma producing corticotrophin-releasing factor. , 1984, Annals of internal medicine.

[97]  N. Ling,et al.  Isolation and partial molecular characterization of pituitary fibroblast growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[98]  K. Kovacs,et al.  Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. , 1984, The New England journal of medicine.

[99]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[100]  D. Nelson,et al.  ACTH-producing pituitary tumors following adrenalectomy for Cushing's syndrome. , 1960, Annals of internal medicine.